
Embecta Investor Relations Material
Latest events

Q3 2025
Embecta
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Embecta Corp
Access all reports
Embecta Corp is a medical technology company focused on the development and manufacturing of diabetes care products. The company specializes in providing devices and solutions for insulin delivery, including insulin syringes and pen needles, aimed at improving the daily management of diabetes. Embecta serves healthcare providers and patients globally, with a mission to support individuals with diabetes in maintaining their health through reliable and accessible products. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Embecta Corp


43rd Annual J.P. Morgan Healthcare Conference 2025
Embecta Corp


Investor Day 2025
Embecta Corp
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
EMBC
Country
🇺🇸 United States